Overview of Dr. Arcasoy
Dr. Arcasoy was recruited to Columbia University/NewYork-Presbyterian Hospital as the Medical Director of Lung Transplant Program in 2001 from the University of Pennsylvania, where he was a key member of the Advanced Lung Disease and Lung Transplantation Program. After his recruitment, he completely turned around the Lung Transplant Program to rank amongst the top 5 to 10 programs in the country with regards to volume and top 1 to 5 programs in terms of patient survival. Under his leadership, the Lung Transplant Program has performed 60-70 transplants annually in the past 7 years with a record number of 84 transplants in 2019. Despite high transplant volumes and very sick pretransplant candidates, the survival of lung transplant recipients has remained significantly above the national average. Currently, 1-year survival of lung transplant recipients at Columbia University is 90%, 5-year survival 68%, and 10-year survival 45%.
Dr. Arcasoy has gained national and international reputation with various leadership roles in many professional organizations and scientific societies. He previously chaired the Thoracic Organ Transplant Committee of the American Society of Transplantation and the Transplant Network Steering Committee of the American College of Chest Physicians. Dr. Arcasoy is a Fellow of the American College of Physicians (FACP), American College of Chest Physicians (FCCP), and American Society of Transplantation (FAST). He serves as a reviewer for many scientific journals. Dr. Arcasoy has been named in America's Top Doctors and Top Doctors: New York Metro area in the past 17 consecutive years. He has also been selected in the New York Times Super Doctors list in the past 10 years.
Dr. Arcasoy's main research interests include outcomes of patients with advanced lung disease before and after lung transplantation and clinical trials in new immunosuppressive therapies.
Office
622 West 168th Street
Floor 14
New York, NY 10032- Is this information wrong?
Education & Training
- Columbia UniversityM.P.H., Public Health in Healthcare Management, 2011 - 2013
- UPMC Medical EducationFellowship, Pulmonary Disease and Critical Care Medicine, 1994 - 1998
- SUNY Health Science Center at BrooklynResidency, Internal Medicine, 1990 - 1994
- Ege Univ- Fac MedClass of 1990
- Tarsus American CollegeBachelors, 1977 - 1984
Certifications & Licensure
- NJ State Medical License 2004 - 2023
- PA State Medical License 1994 - 2002
- NY State Medical License 1993 - 2023
- CT State Medical License 1992 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2003-2014, 2016-2020
- New York Magazine: Top Doctors Castle Connolly, 2002-2007, 2010, 2019-2020
- New York City Super Doctors New York Times Magazine, 2009-2020
- Join now to see all
Clinical Trials
- Intravenous Immunoglobulin (IVIG) in Lung Transplantation Start of enrollment: 2005 Jun 01
- Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-2) Start of enrollment: 2019 Mar 29
- Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1) Start of enrollment: 2019 Apr 02
Publications & Presentations
PubMed
- Lung transplant waitlist outcomes among ABO blood groups vary based on disease severity.Samantha Greissman, Michaela Anderson, Angela Dimango, Harpreet Grewal, Gabriela Magda, Hilary Robbins, Lori Shah, Joseph Costa, Bryan Stanifer, Frank D'-Ovidio, Migue...> ;The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2022 Nov 7
- Impact of Omicron on Lung Transplant Recipients: A Third COVID-19 Surge with Different Outcomes.Jamie Hum, Kemarut Laothamatas, Jenna Scheffert, Margaret Nolan, Genevieve Reilly, Frank D'Ovidio, Luke Benvenuto, Selim M Arcasoy> ;Annals of the American Thoracic Society. 2023 Jan 1
- Quality of Life Outcomes and Associated Symptoms Reported by Lung Transplant Recipients Amidst COVID-19 Pandemic: Applying a Novel Assessment Tool.Sasha Storaasli, Shunichi Nakagawa, Jonathan P Singer, David A Fedoronko, Yuan Zhang, Demetra Tsapepas, Maylin E Rincon, Jenna Scheffert, Luke Benvenuto, Selim M Arcasoy> ;Transplantation proceedings. 2022 Dec 1
- Join now to see all
Journal Articles
- Interobserver variability in grading transbronchial lung biopsies after lung transplantationChest, 1/1/2013
- Pulmonary arteriole gene expression signature in idiopathic pulmonary fibrosisEur Resp J, 1/1/2013
- Variation in PTX3 is Associated With Primary Graft Dysfunction After Lung TransplantationAm J Respir Crit Care Med, 1/1/2012
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- PTX3 Polymorphisms Are Associated with Primary Graft Dysfunction after Lung TransplantationJ Heart Lung Transplant, 1/1/2011
- Elevated PTX3 Concentration Is Associated with Primary Graft Dysfunction after Lung Transplantation in Patients with Idiopathic Pulmonary FibrosisJ Heart Lung Transplant, 1/1/2011
- Donor Lung Surfactant Protein D Gene Polymorphisms are Associated with Bronchiolitis Oblietrans Syndrome and Mortality after Lung TransplantationJ Heart Lung Transplant, 1/1/2011
- Join now to see all
Lectures
- International Collaboration in Lung TransplantationIstanbul, Turkey - 1/1/2013
- Lung Transplantation. 2013 UpdateMedica Health Clinic, Istanbul, Turkey - 1/1/2013
- Lung Transplantation in Interstitial Lung Disease and Pulmonary FibrosisColumbia University College of Physicians and Surgeons and NewYork-Presbyterian Hospital, White Plai - 1/1/2012
- Join now to see all
Other
- Lung Transplant in the COPD PatientLung Health Professional Magazine
1/1/2011 - Pancoast's syndrome and superior (pulmonary) sulcus tumorsArcasoy SM, Jett JR, Schild SE
http://www.uptodate.com/contents/pancoasts-syndrome-and-superior-pulmonary-sulcus-tumors
UpToDate, Wolters Kluwer Health - 2012-03-28
Press Mentions
- Lung Patients See a New Era of TransplantsSeptember 24th, 2006
Grant Support
- Pathogenesis Of Airway Disease In Cystic FibrosisNational Heart, Lung, And Blood Institute1996–1997
Hospital Affiliations
- New York-Presbyterian HospitalNew York, New York
- NewYork-Presbyterian/Columbia University Irving Medical CenterNew York, New York
- NewYork-Presbyterian/Columbia University Irving Medical CenterNew York, New York
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS North Carolina BlueOptions PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Great West PPO
Healthfirst New YorkHIP of New York - Select PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: